Replies to post #8479 on Inovio Pharmaceuticals Inc (INO)

[Everywhereman]

I do not know. That article had no balance. My original article did go over risk, just not enough for them. They also wanted discussion of the balance sheet which is why I added that chart and the stuff after it, which was really not necessary. I had discussed the companies funding and linked to the 10q so people could easily see the data.

Shorting a stock is much more risky then being long, yet no mention in his article of any risk at all. On top of that, J. Kim had mentioned several times that major partnership any day now, yet that was not mentioned in his article as a potential problem. Very strange indeed.